Home › Funds › Sio Capital Management, LLC › RLMD
Sio Capital Management, LLC position in RLMD
RELMADA THERAPEUTICS INC · Health Care
Sio Capital Management, LLC reported holding 3,629,844 shares of RLMD (RELMADA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$13.7M, representing 2.70% of its reported portfolio and ranking #13 among its reported holdings. Sio Capital Management, LLC has disclosed RLMD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Sio Capital Management, LLC's RLMD position evolved
Sio Capital Management, LLC first disclosed a stake in RLMD in Q1 2026 at 965,000 shares (US$6.7M). The position peaked in Q3 2026 at 3,629,844 shares, worth US$13.7M. Across 3 filings, Sio Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,629,844 shares valued at US$13.7M — an increase of 2,626,282 shares quarter over quarter.. Notable position changes include a 262% increase in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 965.00K | $6.72M | New |
| Q2 2026 | 1.00M | $6.94M | Add |
| Q3 2026 | 3.63M | $13.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLMD and 13F data
RLMD (RELMADA THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in RLMD — the largest reported positions include Squadron Capital Management LLC (US$50.9M), Venrock Adviser, LLC (US$47.4M), Spruce Street Capital LP (US$26.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLMD
- Squadron Capital Management LLC 7.35M sh · $50.86M · Q2 2026
- Venrock Adviser, LLC 6.84M sh · $47.36M · Q2 2026
- Spruce Street Capital LP 6.91M sh · $26.06M · Q3 2026
- Jones Hill Capital LP 5.24M sh · $19.75M · Q3 2026
- Ikarian Capital, LLC 2.15M sh · $14.87M · Q2 2026
- Commodore Capital LP 1.43M sh · $9.86M · Q2 2026
- Opaleye Management Inc. 935.00K sh · $6.47M · Q2 2026
- Boxer Capital Management, LLC 842.11K sh · $5.83M · Q2 2026
- GREAT POINT PARTNERS LLC 842.11K sh · $5.83M · Q2 2026
- AdvisorShares Investments LLC 670.86K sh · $2.53M · Q3 2026
- Seven Fleet Capital Management LP 348.26K sh · $2.41M · Q2 2026
- Knott David M Jr 480.00K sh · $1.81M · Q3 2026
More on Sio Capital Management, LLC
FAQ
How long has Sio Capital Management, LLC held RLMD?
Sio Capital Management, LLC has disclosed RLMD holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Sio Capital Management, LLC's current position in RLMD?
As of Q3 2026, Sio Capital Management, LLC holds 3.63M shares of RLMD (RELMADA THERAPEUTICS INC), valued at $13.68M, representing 2.70% of its reported portfolio and ranking #13.
Has Sio Capital Management, LLC been buying or selling RLMD?
In the latest 13F filing (Q3 2026), Sio Capital Management, LLC increased its position in RLMD. The position peaked in Q3 2026 at 3.63M shares.
Which other funds hold RLMD?
Other major institutional holders of RLMD include Squadron Capital Management LLC, Venrock Adviser, LLC, Spruce Street Capital LP, among 67 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.